Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Hass

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Biology of Reproduction|June 1, 1982
Detection and partial characterization of two bovine pregnancy-specific proteinsJ E Butler, W C Hamilton, R G Sasser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Complement factor H or a related protein is a marker for transitional cell cancer of the bladderR Kinders, T Jones, R Root, et al.
Cancer Research|April 1, 1991
Preparation of synthetic polypeptide domains of carcinoembryonic antigen and their use in epitope mappingG M Hass, T J Bolling, R J Kinders, et al.
The American Journal of Pathology|February 1, 1974
Electron microscopic and chemical studies of the vascular changes and edema of lead encephalopathy. A comparative study of the human and experimental diseaseR A Clasen, J F Hartmann, A J Starr, et al.
The Journal of Biological Chemistry|April 25, 2000
Mechanistic studies of the effects of anti-factor H antibodies on complement-mediated lysisM J Corey, R J Kinders, C M Poduje, et al.
The Prostate|September 1, 1994
PR92 antigen in human prostate fluid: elevated levels in prostate cancerB I Carlin, J Marachie, M F Venegas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance proceduresF J Xu, Y H Yu, L Daly, et al.
Cancer|April 1, 1994
OVX1 as a marker for early stage endometrial carcinomaF J Xu, Y H Yu, L Daly, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Biology of Reproduction|June 1, 1982
Detection and partial characterization of two bovine pregnancy-specific proteinsJ E Butler, W C Hamilton, R G Sasser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Complement factor H or a related protein is a marker for transitional cell cancer of the bladderR Kinders, T Jones, R Root, et al.
Cancer Research|April 1, 1991
Preparation of synthetic polypeptide domains of carcinoembryonic antigen and their use in epitope mappingG M Hass, T J Bolling, R J Kinders, et al.
The American Journal of Pathology|February 1, 1974
Electron microscopic and chemical studies of the vascular changes and edema of lead encephalopathy. A comparative study of the human and experimental diseaseR A Clasen, J F Hartmann, A J Starr, et al.
The Journal of Biological Chemistry|April 25, 2000
Mechanistic studies of the effects of anti-factor H antibodies on complement-mediated lysisM J Corey, R J Kinders, C M Poduje, et al.
The Prostate|September 1, 1994
PR92 antigen in human prostate fluid: elevated levels in prostate cancerB I Carlin, J Marachie, M F Venegas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance proceduresF J Xu, Y H Yu, L Daly, et al.
Cancer|April 1, 1994
OVX1 as a marker for early stage endometrial carcinomaF J Xu, Y H Yu, L Daly, et al.
Pageof 6